221 related articles for article (PubMed ID: 31491447)
1. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
Chang HL; Lin JC
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
[TBL] [Abstract][Full Text] [Related]
2. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
Zhu H; Zhang S
J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
[TBL] [Abstract][Full Text] [Related]
4. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
5. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
[TBL] [Abstract][Full Text] [Related]
6. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.
Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z
Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.
Das S; Anczuków O; Akerman M; Krainer AR
Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246
[TBL] [Abstract][Full Text] [Related]
8. The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.
Lin JC; Lee YC; Liang YC; Fann YC; Johnson KR; Lin YJ
Sci Rep; 2017 Mar; 7():44204. PubMed ID: 28276498
[TBL] [Abstract][Full Text] [Related]
9. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
[TBL] [Abstract][Full Text] [Related]
10. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
[TBL] [Abstract][Full Text] [Related]
11. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer.
Lv Y; Zhang W; Zhao J; Sun B; Qi Y; Ji H; Chen C; Zhang J; Sheng J; Wang T; Dominguez D; Liu H; Liu Q; Meng S; Li X; Wang Y
Signal Transduct Target Ther; 2021 Mar; 6(1):108. PubMed ID: 33664238
[TBL] [Abstract][Full Text] [Related]
12. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia regulates alternative splicing of HIF and non-HIF target genes.
Sena JA; Wang L; Heasley LE; Hu CJ
Mol Cancer Res; 2014 Sep; 12(9):1233-43. PubMed ID: 24850901
[TBL] [Abstract][Full Text] [Related]
14. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Aurora kinase A switches m
Li S; Qi Y; Yu J; Hao Y; He B; Zhang M; Dai Z; Jiang T; Li S; Huang F; Chen N; Wang J; Yang M; Liang D; An F; Zhao J; Fan W; Pan Y; Deng Z; Luo Y; Guo T; Peng F; Hou Z; Wang C; Zheng F; Xu L; Xu J; Wen Q; Jin B; Wang Y; Liu Q
Signal Transduct Target Ther; 2022 Apr; 7(1):97. PubMed ID: 35361747
[TBL] [Abstract][Full Text] [Related]
16. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
[TBL] [Abstract][Full Text] [Related]
17. SRSF1-Regulated Alternative Splicing in Breast Cancer.
Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-wide targets of alternative splicing by RBM4 and possible role in cancer.
Markus MA; Yang YH; Morris BJ
Genomics; 2016 Apr; 107(4):138-44. PubMed ID: 26898347
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of regulation of leptin expression in human lung adenocarcinoma cells by hypoxia inducible factor-1alpha: a preliminary study].
Zhang YB; Fang M; He FL; Hua TF; Hu BD; Zhao H; Liu RY
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2848-53. PubMed ID: 19080496
[TBL] [Abstract][Full Text] [Related]
20. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]